Mechanism of Action Selective agonist of the growth hormone secretagogue receptor (GHS-R1a) on pituitary somatotrophs, stimulating GH release without significantly affecting cortisol, prolactin, or ACTH levels
Some studies put the number closer to 40% when you include mild cases that people do not always report to their healthcare providers
On week 7 and loving the results
Metabolic Support Tirzepatide, particularly through mechanisms involving GIP receptors, assists in fat storage management and energy metabolism, boosting weight loss potential beyond GLP-1 agonists alone
Data shows that 1.6 million adults in England, Wales, and Scotland used a GLP-1 medication for weight loss between 2024 and 2025
CJC-1295 is a GHRH (growth hormone-releasing hormone) analog